Your Search Returned 41 tagged news reports
S Global pharmaceutical company Galen has acquired exclusive US rights to market and sell Nuvo's Synera, a topical patch that combines lidocaine, tetracaine and heat. The FDA approved patch is currently indicated to provide local dermal analgesia for
Opioid drug sales increased 110 percent between 2001 and 2012, while overdose deaths from prescription opioids more than quadrupled from 1999 to 2010, the New York Times recently reported. Two lawmakers on the House Energy and Commerce Subcommittee
S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and companies that made waves in
According to the Organic Trade Association industry survey for 2011, organic food sales grew about 13.4% annually from 2002 to 2010, while conventional food sales remained largely flat. That kind of growth is about in line with that of Whole Foods,
District Court in New Jersey, saying Endo's sales of Opana ER, a formulation of oxymorphone hydrochloride, violate three Depomed patents.
Aeropostale (ARO) was downgraded by Keybanc (KEY) to hold from buy as the middle income consumer remains under financial pressure...Piper Jaffray (PJC) to underweight from neutral with a price target of $22 due a uncertain outlook for generic drugs.
GVK Biosciences (GVK BIO), Asia's leading drug discovery research and development CRO, announced on Monday that it has entered into a collaboration agreement with U.S. based Endo Pharmaceuticals focused on discovering novel small molecules targeting
Both companies will pay $18.17 million to the state, plus attorney fees and relator shares. The federal government is also entitled to a share of the total settlement, Abbott's statement said. http://www.bizjournals.com/houston/news/2013/01/04/texas-
Earlier this year, the US Senate Finance Committee opened an investigation into several drugmakers, including Endo Pharmaceuticals, that sell prescription painkillers and their ties to several patient advocacy groups and various physicians due to an
Endo Pharmaceuticals, Bioniche's licensing partner, was conducting the randomized, active-controlled trial. According to Bioniche, the study was not being recruited at the anticipated rate and subsequent to the discussions with FDA about the trial